ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Integrative multi-omics reveals NQO1-mediated airway epithelial injury as a key mechanism of bisphenol A-induced COPD.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Isorhamnetin ameliorates active ulcerative colitis potentially involving the Nrf2-PTGS2 axis: an integrative study from clinical evidence mining to in vivo validation.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Bisphenol A (BPA) is a ubiquitous environmental pollutant, but its relationship with chronic obstructive pulmonary disease (COPD) and the underlying toxicological mechanisms remain unclear. To address this, we employed an integrative multi-omics strategy that included cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) data, Mendelian randomization, network toxicology, molecular docking, molecular dynamics simulation, single-cell transcriptomic analysis, and in vitro experimental validation. Cross-sectional analysis revealed a significant positive association between BPA exposure and COPD prevalence. In the fully adjusted model, each one-unit increase in ln‑transformed BPA (ng/mg creatinine) was associated with a 34% increase in the odds of COPD (OR = 1.34, 95% CI: 1.17-1.54). Mendelian randomization analysis showed that BPA was a potential risk factor for COPD. Through network toxicology and five machine-learning methods, NQO1, HSPA5, and CXCL12 were identified as the hub targets in BPA-induced COPD. Among these, molecular docking and molecular dynamics simulation showed that BPA exhibited the highest binding affinity for NQO1. Single-cell transcriptomic analysis of human lung tissue revealed that NQO1 was predominantly expressed in airway epithelial cells. Real-time PCR and western blot confirmed that BPA exposure significantly decreased NQO1 expression levels in airway epithelial cells. In BPA-treated airway epithelial cells, NQO1 overexpression significantly suppressed mitochondrial reactive oxygen species (ROS) production, prevented mitochondrial membrane potential decline, alleviated intracellular ATP depletion, mitigated mitochondrial structural damage, reduced intracellular ROS accumulation, and attenuated cell viability reduction. Our findings suggest that BPA is a potential risk factor for COPD, and downregulation of NQO1 contributes to the pathogenesis of BPA-induced COPD, potentially through mitochondrial damage in airway epithelial cells.
Indexed as
Identifiers
42489718What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.